Screener
Adaptive Biotechnologies ADPT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206546
FAQ
- What is Adaptive Biotechnologies's free cash flow?
- Adaptive Biotechnologies (ADPT) reported free cash flow of -$10.33M in Q1 2026.
- How has Adaptive Biotechnologies's free cash flow changed year-over-year?
- Adaptive Biotechnologies's free cash flow increased by 65.3% year-over-year, from -$29.74M to -$10.33M.
- What is the long-term trend for Adaptive Biotechnologies's free cash flow?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's free cash flow has grown at a -33.3% compound annual growth rate (CAGR), from -$254.47M to -$50.36M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Adaptive Biotechnologies's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude